Search

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Trial Phase 2 Terminated April 15, 2019

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Trial Phase 2 Terminated April 11, 2019

Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease

Trial N/A Completed April 11, 2019

Precision Medical Diagnosis for Parkinson's Disease - The Quantitative Analysis System for PET/MRI Images in Patients

Trial N/A Unknown April 9, 2019

The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease

Trial N/A Completed April 4, 2019

The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease

Trial N/A Completed April 3, 2019

neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug Trials

Trial N/A Completed April 3, 2019

A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients

Trial N/A Completed April 2, 2019

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Trial Phase 1 Terminated April 2, 2019

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

Trial Phase 3 Terminated April 2, 2019

Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects

Trial Phase 1 Terminated April 2, 2019

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

Trial Phase 2 Completed April 2, 2019

The Study of the Impact of Disclosing Imaging Study Information to Trial Participants

Trial N/A Completed April 2, 2019

Effects of Rhythmic Auditory Cueing on Stepping in Place in Patients With Parkinson's Disease

Trial N/A Completed April 1, 2019

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

Trial Phase 1 Completed March 31, 2019

Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms

Trial Phase 4 Completed March 27, 2019

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Trial Phase 2 Terminated March 26, 2019

Feasibility of the AHA Exergame System in Parkinson's Disease Patients

Trial N/A Completed March 25, 2019

Prism Adaptation Treatment of Parkinson's Disease

Trial N/A Completed March 24, 2019

Impact of Walking Practice on Persons With PD

Trial N/A Terminated March 21, 2019